• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACTL8 通过 PI3K/AKT/mTOR 信号通路促进胃癌的进展。

ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway.

机构信息

Northern Jiangsu People's Hospital, Clinical Teaching Hospital of Medical School, Nanjing University, Yangzhou, China.

Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China.

出版信息

Dig Dis Sci. 2024 Oct;69(10):3786-3798. doi: 10.1007/s10620-024-08649-6. Epub 2024 Sep 25.

DOI:10.1007/s10620-024-08649-6
PMID:39322809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11489201/
Abstract

BACKGROUND

Actin-like protein 8 (ACTL8) significantly correlates with tumor growth and prognosis across various cancer types. Nevertheless, the potential relationship between ACTL8 and gastric cancer (GC) remains uncertain.

OBJECTIVE

This study aimed to elucidate the role of ACTL8 in human GC cells and to explore its mechanism.

METHODS

Bioinformatics analysis tools, such as GEPIA2, Kaplan-Meier, and STRING, were utilized for a comprehensive investigation of the characteristics and functional roles of ACTL8 in GC, including differential expression, prognostic value, and related signaling pathways. Subsequently, gene expression analyses, cell function assays, and signaling pathway experiments were conducted to verify key findings.

RESULTS

Bioinformatics analysis showed that ACTL8 was significantly elevated in GC and closely associated with poor prognosis. Gene expression experiments confirmed the bioinformatics results. Furthermore, ACTL8 knockdown markedly reduced GC cell proliferation and inhibited migration and invasion. Mechanistically, a significant increase in the phosphorylation levels of signaling proteins was observed in GC cells following ACTL8 overexpression, and PI3K/Akt/mTOR pathway inhibitors could reverse this effect.

CONCLUSION

ACTL8 expression is significantly upregulated in GC cells and is closely correlated with poor patient prognosis. Further mechanistic studies revealed that ACTL8 may promote GC cell migration and proliferation through activation of the PI3K/Akt/mTOR signaling pathway. Consequently, ACTL8 emerges as a promising therapeutic target for GC.

摘要

背景

肌动蛋白样蛋白 8(ACTL8)与多种癌症类型的肿瘤生长和预后显著相关。然而,ACTL8 与胃癌(GC)之间的潜在关系尚不确定。

目的

本研究旨在阐明 ACTL8 在人 GC 细胞中的作用及其机制。

方法

利用 GEPIA2、Kaplan-Meier 和 STRING 等生物信息学分析工具,全面研究 ACTL8 在 GC 中的特征和功能作用,包括差异表达、预后价值和相关信号通路。随后,进行基因表达分析、细胞功能测定和信号通路实验,以验证关键发现。

结果

生物信息学分析表明,ACTL8 在 GC 中显著上调,与不良预后密切相关。基因表达实验证实了生物信息学的结果。此外,ACTL8 敲低显著降低 GC 细胞的增殖,并抑制迁移和侵袭。机制上,ACTL8 过表达后观察到 GC 细胞中信号蛋白的磷酸化水平显著增加,而 PI3K/Akt/mTOR 通路抑制剂可以逆转这种效应。

结论

ACTL8 在 GC 细胞中表达显著上调,与患者预后不良密切相关。进一步的机制研究表明,ACTL8 可能通过激活 PI3K/Akt/mTOR 信号通路促进 GC 细胞的迁移和增殖。因此,ACTL8 成为 GC 的一个有前途的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/ce89fd5cf3b7/10620_2024_8649_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/1a7e2a351ead/10620_2024_8649_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/dca353d33e84/10620_2024_8649_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/b98d3a05a0db/10620_2024_8649_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/4142c4a01595/10620_2024_8649_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/34cbf593031c/10620_2024_8649_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/ac4d6c04bd86/10620_2024_8649_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/03e9d70cfc1d/10620_2024_8649_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/48194c0f21ae/10620_2024_8649_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/ce89fd5cf3b7/10620_2024_8649_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/1a7e2a351ead/10620_2024_8649_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/dca353d33e84/10620_2024_8649_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/b98d3a05a0db/10620_2024_8649_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/4142c4a01595/10620_2024_8649_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/34cbf593031c/10620_2024_8649_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/ac4d6c04bd86/10620_2024_8649_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/03e9d70cfc1d/10620_2024_8649_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/48194c0f21ae/10620_2024_8649_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba95/11489201/ce89fd5cf3b7/10620_2024_8649_Fig9_HTML.jpg

相似文献

1
ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway.ACTL8 通过 PI3K/AKT/mTOR 信号通路促进胃癌的进展。
Dig Dis Sci. 2024 Oct;69(10):3786-3798. doi: 10.1007/s10620-024-08649-6. Epub 2024 Sep 25.
2
Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.环状 RNA hsa_circ_0010882 通过调控 PI3K/Akt/mTOR 信号通路促进胃癌的进展。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1142-1151. doi: 10.26355/eurrev_202002_20165.
3
Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.炭疽毒素受体 1/肿瘤内皮标志物 8 通过激活 PI3K/AKT/mTOR 信号通路促进胃癌进展。
Cancer Sci. 2020 Apr;111(4):1132-1145. doi: 10.1111/cas.14326. Epub 2020 Feb 19.
4
NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.NUCKS1 通过上调 IGF-1R 并随后激活 PI3K/Akt/mTOR 信号通路促进胃癌细胞侵袭。
Carcinogenesis. 2019 Apr 29;40(2):370-379. doi: 10.1093/carcin/bgy142.
5
Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.miR-20a-5p 诱导 WTX 缺失通过调控 PI3K/AKT 信号通路促进胃癌进展。
J Exp Clin Cancer Res. 2020 Oct 8;39(1):212. doi: 10.1186/s13046-020-01718-4.
6
HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.HOXB13 通过上调 IGF-1R 并随后激活 PI3K/AKT/mTOR 信号通路促进胃癌细胞迁移和侵袭。
Life Sci. 2021 Aug 1;278:119522. doi: 10.1016/j.lfs.2021.119522. Epub 2021 Apr 21.
7
CYP2E1 changes the biological function of gastric cancer cells via the PI3K/Akt/mTOR signaling pathway.CYP2E1 通过 PI3K/Akt/mTOR 信号通路改变胃癌细胞的生物学功能。
Mol Med Rep. 2020 Feb;21(2):842-850. doi: 10.3892/mmr.2019.10890. Epub 2019 Dec 17.
8
Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.长链非编码RNA XLOC_006753通过PI3K/AKT/mTOR信号通路促进胃癌细胞多药耐药性的发展。
Cell Physiol Biochem. 2018;51(3):1221-1236. doi: 10.1159/000495499. Epub 2018 Nov 27.
9
CDK12 Promotes the Proliferation, Migration, and Angiogenesis of Gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling Pathway.CDK12 通过激活 PI3K/AKT/mTOR 信号通路促进胃癌的增殖、迁移和血管生成。
Appl Biochem Biotechnol. 2023 Nov;195(11):6913-6926. doi: 10.1007/s12010-023-04436-7. Epub 2023 Mar 23.
10
Inhibition of PI3K/Akt/mTOR Signaling Pathway Suppresses 5-Fluorouracil Resistance in Gastric Cancer.抑制 PI3K/Akt/mTOR 信号通路可增强胃癌对 5-氟尿嘧啶的敏感性。
Mol Biotechnol. 2024 Dec;66(12):3640-3654. doi: 10.1007/s12033-023-00966-x. Epub 2023 Nov 24.

引用本文的文献

1
Identification of clusters related to programmed cell death and potential prognostic biomarkers for immunotherapy response in endometrial cancer.子宫内膜癌中与程序性细胞死亡相关的簇的鉴定及免疫治疗反应的潜在预后生物标志物
Sci Rep. 2025 Jul 1;15(1):22165. doi: 10.1038/s41598-025-06672-9.
2
Treatment strategies targeting the phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin pathway against triple-negative breast cancer.针对磷酸肌醇3激酶/蛋白激酶B/雷帕霉素作用机制靶点通路治疗三阴性乳腺癌的策略
World J Clin Oncol. 2025 May 24;16(5):104623. doi: 10.5306/wjco.v16.i5.104623.

本文引用的文献

1
KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway.KIRREL 通过 PI3K/AKT/mTOR 通路促进胃癌细胞的增殖和血管生成。
J Cell Mol Med. 2024 Jan;28(1):e18020. doi: 10.1111/jcmm.18020. Epub 2023 Nov 1.
2
Serine protease PRSS56, a novel cancer-testis antigen activated by DNA hypomethylation, promotes colorectal and gastric cancer progression via PI3K/AKT axis.丝氨酸蛋白酶PRSS56是一种由DNA低甲基化激活的新型癌-睾丸抗原,它通过PI3K/AKT轴促进结直肠癌和胃癌的进展。
Cell Biosci. 2023 Jul 3;13(1):124. doi: 10.1186/s13578-023-01060-0.
3
Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms.
肿瘤转移中上皮-间质转化(EMT)的异质性和可塑性:关注部分 EMT 和调控机制。
Cell Prolif. 2023 Jun;56(6):e13423. doi: 10.1111/cpr.13423. Epub 2023 Feb 19.
4
Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2/FGFR1/PI3K/AKT axis.癌症相关成纤维细胞分泌的IGFBP7通过FGF2/FGFR1/PI3K/AKT轴增强肿瘤相关巨噬细胞浸润来促进胃癌。
Cell Death Discov. 2023 Jan 21;9(1):17. doi: 10.1038/s41420-023-01336-x.
5
Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway.载脂蛋白C-II通过PI3K/AKT/mTOR途径诱导上皮-间质转化以促进胃癌腹膜转移。
Clin Transl Med. 2021 Aug;11(8):e522. doi: 10.1002/ctm2.522.
6
Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.肌动蛋白样蛋白8通过激活PI3K/AKT/mTOR信号通路促进三阴性乳腺癌进展。
Onco Targets Ther. 2021 Apr 12;14:2463-2473. doi: 10.2147/OTT.S291403. eCollection 2021.
7
TIMER2.0 for analysis of tumor-infiltrating immune cells.TIMER2.0 用于分析肿瘤浸润免疫细胞。
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407.
8
Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.肌动蛋白样蛋白 8 促进肺腺癌细胞的增殖、集落形成、促血管生成、迁移和侵袭。
Thorac Cancer. 2020 Mar;11(3):526-536. doi: 10.1111/1759-7714.13247. Epub 2020 Jan 21.
9
Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version).《中国胃癌诊疗规范(2018年版)》(英文版)
Chin J Cancer Res. 2019 Oct;31(5):707-737. doi: 10.21147/j.issn.1000-9604.2019.05.01.
10
Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma.口腔鳞状细胞癌中与临床病理参数及预后相关生物标志物的筛选与鉴定
Exp Ther Med. 2019 Nov;18(5):3579-3587. doi: 10.3892/etm.2019.7998. Epub 2019 Sep 11.